Decrease in hiv provirus in peripheral blood mononuclear cells during zidovudine and human ril-2 administration

Journal of Acquired Immune Deficiency Syndromes

Volumn 5, Issue 1, 1992, Pages 52-59

  Clark, A G ^a   Holodniy, M ^a   Schwartz, D H ^a   Katzenstein, D A ^a   Merigan, T C ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Gene amplification; Human immunodeficiency virus; Interleukin 2; Peripheral blood mononuclear cells; Quantification; Zidovudine

Indexed keywords

RECOMBINANT INTERLEUKIN 2; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE; ORAL DRUG ADMINISTRATION;

DNA, VIRAL; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMAN; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; POLYMERASE CHAIN REACTION; PROVIRUSES; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ZIDOVUDINE;

EID: 0026515241     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Schwartz DH, Skowron G, Merigan TC. Safety and effect of interleukin 2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus. J Acquit Immune Defic Syndr 1991; 4:11-23.
2. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med 1990; 322:941-9.
3. Fauci A. The human immunodeficiency virus: infectivity and mechanism of pathogenesis. Science 1988; 239:817-22.
4. Centers for Disease Control Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986; 35:334-9.
5. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36:35-9.
6. MacDonell KB, Chmiel JS, Goldsmith J, Wallemark CB, Steinberg J, Byers E, Phair JP. Prognostic usefulness of the Walter Reed staging classification for HIV infection. J Ac-quir Immune Defic Syndr 1988; 1:367-74.
7. Redfield RR, Wright DC, Tramont EC. The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Merf 1988; 314:131-2.
8. Wolinsky SM, Rinaldo CR, Kwok S, et al. Human immunodeficiency virus type 1 (HIV-1) infection: a median of 18 months before a diagnostic western blot. Ann Intern Med 1989; 111:961-7.
9. Hewlett IK, Laurian Y, Epstein J, Hawthorne CA, Ruta M, Allain JP. Assessment by gene amplification and serological markers of transmission of HIV-1 from hemophiliacs to their sexual partners and secondarily to their children. J Acquir Immune Defic Syndr 1990; 3:714-20.
10. Kwok S, Mack DH, Mullis KB, et al. Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. J Virol 1987; 61:1690-4.
11. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJL. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990; 64:864-72.
12. Abbott MA, Poiesz BJ, Byrne BC, Kwok S, Sninsky JJ, Ehrlich GD. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J Infect Dis 1988; 158:1158-69.
13. Davis GR, Blumeyer K, DiMichele LJ, et al Detection of human immunodeficiency virus type 1 in AIDS patients using amplification-mediated hybridization analyses: repro-ducibility and quantitative limitations. J Infect Dis 1990; 162:13-20.
14. Dickover RE, Donovan RM, Goldstein E, Dandekar S, Bush CE, Carlson JR. Quantitaton of human immunodeficiency virus DNA by using the polymerase chain reaction. J Clin Microbiol 1990; 28:2130-3.
15. Holodniy M, Katzenstein DA, Sengupta S, et al. Detection and quantification of HIV RNA in patient serum using the polymerase chain reaction. J Infect Dis 1991; 163:862-6.
16. Schnittman SM, Greenhouse JJ, Psallidopoulos MC, Baseler M, Salzman NP, Fauci AS, Lane HC. Increasing viral burden in CD4 + T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosupression and clinical disease. Ann Intern Med 1990; 113:438-43.
17. Aoki S, Yarchoan R, Thomas RV, Pluda JM, Marczyk K, Broder S, Mitsuya H Quantitative analysis of HIV-1 proviral DNA in peripheral blood mononuclear cells from patients with AIDS or ARC: decrease of proviral DNA content following treatment with 2′, 3′-dideoxyinosine (ddI) AIDS Res Hum Retroviruses 1990; 6:1331-9.
18. Levenson C, Chang C. Non-isotopically labeled probes and primers. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR protocols: a guide to methods and applications. Berkeley, California: Academic Press, 1990:99-112.
19. Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, Corey L. Plasma viremia in human immunodeficiency virus. New Engl J Med 1989; 321:1626-30.
20. Ehrnst A, Sonnerberg S, Bergdahl S, Strannegard O. Efficient isolation of HIV from plasma during different stages of HIV infection. J Med Virol 1988; 26:23-32.